Residents of Nakuru town have raised a red flag over the continued sale of a defective children’s drug by chemists days after it was recalled by the manufacturer.
The residents, who spoke to HiviSasa.com on Wednesday evening at Nakuru town, disclosed that pharmacies were still selling the panadol syrup to unsuspecting customers.
Grace Kimani, a mother of three, said she was almost sold the drug by a local drug outlet she had visited to buy medicine from, for her sick son.
“A pharmacist almost sold me the drug, but l was quick to reject it because l was aware it had been withdrawn by the manufacturer,” said Ms Kimani.
Other residents also revealed that they had declined the drug presented to them by pharmacists on several occasions.
A spot check in a number of chemists in the town revealed that the drug was still being sold.
GlaxoSmithKline, the mother company that manufactured the drug, recalled it following complaints over its paracetamol levels and the syringe used to administer it.
Already, the Pharmaceutical Society of Kenya president Paul Mwaniki, has cautioned families against using the panadol syrup which she said if used continuously for a period of time will affect the liver.
Mr Mwaniki further said the quality of medicines and health products can be highly compromised if regulations are not strictly enforced.
He called for urgent regulation and quality assurance enforcement in both the private and public facilities to get rid of harmful drugs consumption.
The pharmacists' umbrella professional body asked the national government and the county governments to enforce withdrawal of Panadol syrup from chemists until the manufacturer rectifies its dosage.
Parents now want the government to intervene and have the drugs removed from the shelves.